Prognostic model for unresectable hepatocellular carcinoma treated with transarterial therapy plus TKIs and anti-PD-1 antibodies
{{output}}
Background: Transarterial therapy, including transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC), has long been a cornerstone in the management of unresectable hepatocellular carcinoma (uHCC).... ...
